Cooperative interaction between ERα and the EMT-inducer ZEB1 reprograms breast cancer cells for bone metastasis

被引:0
|
作者
Nastaran Mohammadi Ghahhari
Magdalena K. Sznurkowska
Nicolas Hulo
Lilia Bernasconi
Nicola Aceto
Didier Picard
机构
[1] Université de Genève,Département de Biologie Cellulaire
[2] Sciences III,Department of Biology
[3] Institute of Molecular Health Sciences,Institute of Genetics and Genomics of Geneva
[4] ETH Zurich,undefined
[5] Université de Genève,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The epithelial to mesenchymal transition (EMT) has been proposed to contribute to the metastatic spread of breast cancer cells. EMT-promoting transcription factors determine a continuum of different EMT states. In contrast, estrogen receptor α (ERα) helps to maintain the epithelial phenotype of breast cancer cells and its expression is crucial for effective endocrine therapies. Determining whether and how EMT-associated transcription factors such as ZEB1 modulate ERα signaling during early stages of EMT could promote the discovery of therapeutic approaches to suppress metastasis. Here we show that, shortly after induction of EMT and while cells are still epithelial, ZEB1 modulates ERα-mediated transcription induced by estrogen or cAMP signaling in breast cancer cells. Based on these findings and our ex vivo and xenograft results, we suggest that the functional interaction between ZEB1 and ERα may alter the tissue tropism of metastatic breast cancer cells towards bone.
引用
收藏
相关论文
共 50 条
  • [1] Cooperative interaction between ERα and the EMT-inducer ZEB1 reprograms breast cancer cells for bone metastasis
    Ghahhari, Nastaran Mohammadi
    Sznurkowska, Magdalena K.
    Hulo, Nicolas
    Bernasconi, Lilia
    Aceto, Nicola
    Picard, Didier
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [3] Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer
    Hua-Tao Wu
    Hui-Ting Zhong
    Guan-Wu Li
    Jia-Xin Shen
    Qian-Qian Ye
    Man-Li Zhang
    Jing Liu
    Journal of Translational Medicine, 18
  • [4] Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer
    Wu, Hua-Tao
    Zhong, Hui-Ting
    Li, Guan-Wu
    Shen, Jia-Xin
    Ye, Qian-Qian
    Zhang, Man-Li
    Liu, Jing
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [5] Metastasis and chemoresistance in breast cancer: Crucial function of ZEB1/ 2 proteins
    Doodmani, Seyed Mohammad
    Safari, Mohamad Hosein
    Akbari, Mohammadarian
    Farahani, Najma
    Alimohammadi, Mina
    Aref, Amir Reza
    Tajik, Fatemeh
    Maghsoodlou, Amin
    Daneshi, Salman
    Tabari, Teimour
    Taheriazam, Afshin
    Entezari, Maliheh
    Nabavi, Noushin
    Hashemi, Mehrdad
    PATHOLOGY RESEARCH AND PRACTICE, 2025, 267
  • [6] The novel potential metastasis biomarkers in Zeb1 interactome after EMT induction in MCF7 breast carcinoma cells
    Pozdnyakov, Danila Y.
    Shabelnikov, Sergey V.
    Mittenberg, Alexey G.
    CELL DEATH DISCOVERY, 2020, 6 (01)
  • [7] EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells
    Pablo Lindner
    Sushmita Paul
    Markus Eckstein
    Chuanpit Hampel
    Julienne K. Muenzner
    Katharina Erlenbach-Wuensch
    Husayn P. Ahmed
    Vijayalakshmi Mahadevan
    Thomas Brabletz
    Arndt Hartmann
    Julio Vera
    Regine Schneider-Stock
    Cell Death & Disease, 11
  • [8] ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
    Wei Song
    Lin Tang
    Yumei Xu
    Qian Sun
    Fang Yang
    Xiaoxiang Guan
    Journal of Experimental & Clinical Cancer Research, 36
  • [9] ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
    Song, Wei
    Tang, Lin
    Xu, Yumei
    Sun, Qian
    Yang, Fang
    Guan, Xiaoxiang
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [10] Meso-Hannokinol inhibits breast cancer bone metastasis via the ROS/JNK/ZEB1 axis
    Zhu, Yuan
    Yin, Wei-feng
    Yu, Pei
    Zhang, Chao
    Sun, Ming-hui
    Kong, Ling-yi
    Yang, Lei
    PHYTOTHERAPY RESEARCH, 2023, 37 (06) : 2262 - 2279